Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMULA Lac
NCT06594068Phase 4Recruiting
- Sponsor
- AstraZeneca
- Start
- Jan 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 4 trial of anifrolumab in systemic lupus erythematosus (SLE), sponsored by AstraZeneca. Started Jan 2026; status: recruiting.
02
Drugs
anifrolumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT06594068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594068.